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I. I INTRODUCTION 
A. Hi story and D1scussion of the Problem 
1. The Question of the Conversion of Patty Acids to Carbohydrate. 
The ability of the animal body to produce a net synthesis 
of fat from ingested carbohydrate has been a well-established 
fact since the classical studies of Lawes and Gilbert (1, 2) 
over a century ago. These investigators demonstrated by balance 
experiments that animals deposited more fat than was fed in the 
diet. Further confirmation of the body's ability to transform 
dietary carbohydrates into fat was provided by Schoenheirner and 
Rittenberg's studies (3) in which deuterium was used as a tool to 
measure the synthetic process. The quantitative as well as the 
qualitative aspects of this conversion were further studied by 
Longerecker in 1939 (4). 
However, it is much more difficult to demonstrate the reverse 
of this, the net synthesis bj animal tissues of carbohydrate 
from fatty acids or from products of their metabolism. Though 
there have been several claims that such a synthesis does occur, 
the experimental evidence in general has been equivocal or open 
to much criticism. For every investigator who has claimed to 
have demonstrated this conversion it seems there has been someone 
else who has been unable to do so by using similar methods. 
One of the earliest approaches to the problem of gluconeo- 
genesis from fatty acids was the feeding of diets consisting 
solely of fats and then examining the liver for signs of Increased 
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glycogen storage. By such methods Takao (5), Burn and Ling (6) 
and Magnusson (7) claimed large increases in liver glycogen. In 
contrast Bodey (8), Gregg (9) and Greisheimer (10) found little 
or no increase. The small increments in the latter experiments 
could readily be accounted for by the glycerol content of the fats, 
for the feeding of glycerol alone was found to produce a marked 
increase in liver glycogen (10). Even if the liver glycogen were 
consistently elevated in fat-fed animals it is not proof that the 
glycogen came from fats per se---it might have come from protein 
or from carbohydrates in other body tissues. 
Other investigators have attempted to demonstrate by means 
of low respiratory quotients that fat can be converted to 
carbohydrate. By feeding high-fat diets Hawley, Johnson and 
Murlin (80) were able to produce respiratory quotients below 0.70 
in humans and Hawley and Murlin (81) were able to do the same 
with a pig. Likewise Lyon, Dunlop and Stewart (82) found R. Q,.'s 
as low as 0.59 in obese human subjects on reducing diets. These 
authors claim the low R. Q.'s obtained indicate a conversion of 
fat to carbohydrate. Their reasoning is as follows. Since the 
theoretical R. Q, for the oxidation of fat is 0.70 a non-protein 
R. Q. of less than 0.70 means the body is retaining excess 02 
to form oxygen-rich carbohydrate from fat. 
However, is an R. Q,. of less than 0.70 really proof of a 
gluconeogenesis from fat? Apparently not, for as Mitchell points 
out in his excellent review of the subject (11) gluconeogenesis 
from amino acids, desaturation of fatty acids and other inter¬ 
mediary oxidative reactions could also play a role in lowering 
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the R. Q. below 0.70. Also there are many errors In the correction 
of R. Q.'s for protein metabolism, one source of error being the 
body's delay in excreting urinary nitrogen. The nitrogen used 
in the calculation of R. Q.’s often comes in part from the cata¬ 
bolism of food given the animal in the meal prior to the test 
meal. Also, an R. Q. greater than 0.70 does not prove fat is 
not being converted to carbohydrate for a simultaneous oxidation 
of sugar would elevate the R. Q. Thus one cannot conclude 
definitely whether or not fats can give rise to carbohydrates 
by studying the respiratory quotients of animals. 
Another approach has been that of liver perfusion studies. 
By such methods Burn and Marks (12) and Jost (13) claimed to 
be able to demonstrate the formation of carbohydrate in the 
liver from fat. However, Mitchell (11) criticizes these studies 
and claims that the glycogen increment may have been due to 
lactic acid formed while the experiments were being set up or 
from glycerol liberated from the fats present in the liver tissue. 
Gregg (14) in perfusion experiments with livers from fat-fed 
cats and dogs could not demonstrate any support for the theory 
of gluconeogenesis from fatty acids. 
Some investigators have attempted to account quantitatively 
for the sugar excreted in the urine of depancreatized dogs in 
response to epinephrine injections. By such methods Chaikoff 
and Weber (18) concluded that in a few of their experiments the 
extra urinary sugar produced in response to the injection of 
epinephrine must have been derived in part from .fatty acids. 
Yet in similar experiments Eollman, Mann and Wilhelmj (19) 
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could produce no evidence for the formation of sugar from fat. 
In recent years many investigators have attacked the 
question of the conversion of fats to carbohydrates by means of 
studies with radioisotopes of carbon. In 194-3 Buchanan et al. 
(20) fed carboxyl-labeled acetate, propionate and butyrate to 
fasted rats and found radioactivity in the liver glycogen. Here 
for the first time was conclusive evidence that the carbon atoms 
of short chain fatty acids can find their way into carbohydrate 
molecules. Strisower et al. (21) demonstrated In 1951 that G^-h 
is found in the blood glucose of rats fed tripalmitin-6-C^'’ , a 
long chain fatty acid. 
The mechanisms by which labeled carbon atoms of fatty acids 
find their way into carbohydrate molecules has been studied by 
numerous investigators (22 - 28) using isotopes of carbon. 
Their results indicate that the main pathway is the degradation 
of fatty acids into 2-carbon fragments (acetyl-CoA) which then 
traverse the Kreb9s cycle and finally form glucose via the re¬ 
verse of the Embden - Meyerhof scheme of glycolysis. 
Now that it has been demonstrated that labeled carbons of 
fats find their way into carbohydrate molecules the question of 
net synthesis of sugar from fats arises. If it is assumed that 
for every two carbons entering the Kreb’s cycle as acetyl-CoA 
two carbon atoms must be evolved as C02 obviously no net synthesis 
can take place. However, if substances other than acetate enter 
the cycle they could give rise to the liberated C02 while the 
carbons of acetate produced a net synthesis of carbohydrate. 
Whether or not such substances actually enter the Kreb*s cycle 
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can be determined by measuring the CO2 ratio (29) where 
G^Op derived from acetate-l-C^ 
G^-2'02 derived from acetate-2-C-^ 
If acetic acid is the only substance entering the Kreb*s cycle 
the CO2 ratio will equal 1.0 after approximately a dozen'turns 
of the cycle. This can be demonstrated as follows; If one 
traces the carbon atoms of CHy-^COOH (^designates a radioactive 
atom) through the citric acid cycle it will be seen that no 
labeled C02 is liberated after the first turn but that 100$ 
of the C-* is liberated as C**02 after the second revolution. 
When C^Hy-COOH is fed into the citric acid cycle no labeled 
COg is set free during either the first or second turns. On 
the third turn 50$ of the is liberated as and after the 
4th turn 75% has been given off. By the twelfth revolution 
99.92>7o (29) of the labeled carbon ha.s taken the form of carbon 
dioxide. With each subsequent turn the liberated C* approaches 
closer to 100$ which is the value liberated when CHy-C*~00H was 
fed into the cycle. Hence the CO2 ratio approaches 1.0 after 
several turns of the cycle. 
If unlabeled substances enter the Kreb's cycle at the same 
time as acetate-l-C-^ or acetate-2-C-*-^ they will dilute the 
specific activities of the Kreb’s cjrcle intermediates. Weinman 
et al. (29) demonstrate mathematically that this would produce 
a CO2 ratio greater than 1.0 when the inflow and outflow of 
labeled carbons has become constant. 
Various investigators have made actual measurements of 
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the C02 ratio by using fasted rats (30), sheep Xactating mam¬ 
mary gland slices (31)» lactating qows (32) and rat liver slices 
(33, 34). The values obtained have ranged from 1,0 to 4.8. 
Hence it would appear that acetate is not the only source of 
carbon atoms entering the Kreb's cycle. Presumably substances 
such as glutamate and aspartate can enter the cycle by forming 
alpha-ketoglutarate and oxaloacetate respectively. Likewise 
proline, hydroxyproline, ornithine, arginine and histidine can 
enter the cycle by first forming glutamate as a metabolic 
breakdown product. 
^1 so Weinman et al. (29) point out that from various ex¬ 
perimental observations and thermodynamic considerations the 
reaction 
Oxaloacetate + ATP Phosohopyruvate •* ALP + C02 
proceeds more rapidly to the right than to the left, at least 
in the mammalian liver. Thus it would appear that fatty acids 
can be degraded to 2-carbon acetyl fragments which can then 
enter the Kreb's cycle to form oxaloacetate. For each of these 
acetyl fragments entering the cycle two carbons from substances 
such as glutamate or aspartate are liberated as C02. The oxalo¬ 
acetate then gives rise to a net synthesis of carbohydrate. In 
summary, for every two carbons of fat forming glucose two car¬ 
bons from another compound such as an amino acid must be uti¬ 
lized to maintain the Kreb's cycle. Hence it is possible to 
produce a synthesis of carbohydrate from fat via the Kreb's 
cycle though such a synthesis is not the same as the net gain of 
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fat from carbohydrate where a third substance (protein) is not 
needed. 
2„ Ketone Bodies and Their Relationship to the Glycogen Content 
of the Heart and Other Tissues. 
Not only ha.s there been much interest in the conversion of 
fatty acids to sugar but also in the possible conversion of 
ketone bodies --- acetoacetic acid, beta-hydroxybutyric acid 
and acetone --- to glucose since they are products of fat cata¬ 
bolism. Numerous investigators have demonstrated that aceto- 
acetate arises largely by the recondensation of acetyl units 
formed in the degradation of fatty acids but that a small amount 
is formed from the beta-oxidation of butyric acid which is an 
incomplete breakdown product of fatty acids (22, 35, 36, 37, 
38, 39). The utilization of acetoacetic acid in animal tissues 
is commonly ascribed to two types of metabolic processes --- 
reduction to beta-hydroxybutyric acid and oxidation to COg and 
H2O after degradation to acetyl fragments. The reduction and 
its reversibility was first observed by Friedmann and Maase 
(40) and Wakeman and Dakin (41). Its oxidative breakdown was 
demonstrated in experiments by Snapper and Grunbaum (42). To 
a small extent acetoacetic acid is decarboxylated to acetone 
by animal tissues but Sakarni (43) has ruled out acetoacetate as 
the major source of acetone. The major precursor of acetone 
is not known. Some evidence has been presented that it may 
arise from leucine (44, 45). 
Since acetoacetic acid or beta-hydroxybutyric acid is not 
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readily utilized by the liver (46) but is readily assimilated by 
striated muscle (47) arid by cardiac muscle (48, 49) any con¬ 
version to glucose should be looked for in these extrahepatic 
tissues, Nagler (50) incubated surviving rat diaphragm in phos¬ 
phate buffer medium containing glucose (200 mgm./o), glucose and 
insulin (0.05 unit per 1.0 ml), and glucose, insulin and aceto- 
acetate (50 mgm./»). No effect of acetoacetate on glycogen 
synthesis was observed. Parnes and Wertheimer (51) and Chari 
and Wertheimer (53) reported that acetoacetate depressed glycogen 
synthesis in the rat diaphragm, even in the presence of insulin. 
Nor has anyone else been able to demonstrate a conversion of 
ketone to carbohydrate in striated muscle. 
Of especial interest is the well extablished fact that 
conditions producing ketosis in animals cause an increase in the 
glycogen content of the myocardium. Long and Evans found in 
1932 (52) that fasted rats have a higher cardiac glycogen level 
than fed animals. In 1944 Lackey et al. (54) found that rats 
made diabetic with alloxan likewise had a significantly elevated 
cardiac glycogen whereas the glycogen content of the liver and 
skeletal muscle was decreased in comparison to control animals. 
In 1945 Lackey, Bunde and Harris (55) presented evidence 
that there is no correlation between cardiac glycogen and blood 
sugar or blood lactic acid levels but that there is a direct 
correlation between the blood ketone level and heart glycogen in 
rats under varied dietary conditions. There was no relation¬ 
ship between the concentration of blood ketone bodies and liver 
and muscle glycogen. Later this same group of investigators (56) 
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infused fasted and fed rats with sodium acetoacetate and sodium 
beta-hydroxybutyrate for four hours and found a marked increase 
in cardiac glycogen in each case. Of interest is the fact that 
in the fasted rats a much higher blood ketone level was needed 
to elevate the cardiac glycogen than in the case of the fed 
animals. Thus the blood ketone concentration does not appear 
to be the only factor controlling the level of cardiac glycogen 
in these experiments. 
Since conditions producing ketosis unquestionably cause a 
rise in cardiac glycogen the possibility of a direct conversion 
of ketone bodies to glycogen in the heart naturally arises. 
Stadie and Haugaard in 1947 (57) could not demonstrate any 
glycogen synthesis in rat heart slices which were incubated with 
sodium beta-hydroxybutyrate. In 1956 Meyer and Bow (58) infused 
rats with Na acetoacetate-3-C^4 and discovered no radioactivity 
whatsoever in the cardiac glycogen after 2.5 hours of infusion 
and concluded that "the net increase in heart carbohydrate 
accompanying ketonemia represents some secondary and yet unde- 
termined. influence of ketone bodies." 
If there are any conditions under which the animal heart is 
able to convert ketone bodies to glycogen what pathways might 
be involved? Following are possibilities that have frequently 
been considered: 
1) Acetoacetate acetyl-CoA*“-»»— glucose via the 
Kreb's cycle and the reverse of the Embden - Meyer¬ 
hof scheme of glycolysis. 
2) Acetoacetate-“~#**”Qxalo&cetate —-^glucose by omega 
oxidation of acetoacetate. 
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3) Acetoacetate —butyrate*—»-» succinate-—•-oxalo- 
acetate-—•—glucose by omega oxidation of butyrate 
to succinate, 
4) The Thunberg reaction, ie., the oxidative con¬ 
densation of two moles of acetate to succinate (59). 
5) (Acetoacetate —*■»>) acetone..^ pyruvate-*--^-glucose. 
Meyer and Bow (60) perfused isolated dog’s hearts with Na 
acetoacetate-t-G-^ and found malate and succinate to be labeled 
almost exclusively in the carboxyl carbon which is compatible 
with pathway 1) and not 2) or 3). If 2) and 3) are mechanisms 
utilized by the heart acetoacetate-3-C^ should label malate and 
succinate in the methylene carbons. This was not the case. 
3) is also unlikely in view of Lorber’s demonstration (6l) that 
butyrate is metabolized by animal tissues only in the conventional 
manner --- beta-oxidation to 2 acetyl-CoA. Meyer and Bow (60) 
claim to have demonstrated the same thing in the isolated dog’s 
heart in an unpublished observation. 
Though Foster has presented evidence that the Thunberg 
condensation does occur in the mold, Rhizopus nigricans, (62, 
63) the reaction has never been demonstrated satisfactorily in 
animal tissues. 
To a limited extent acetone gives rise to acetoacetate in 
the liver of rats by earboxylation (64). Also the acetone 
methyl carbon has been demonstrated to give rise to ’’formate", 
probably by a 2- and 1-carbon cleavage in which acetate is 
formed (43). But does acetone produce a 3-carbon intermediate 
of glycolysis such as pyruvate? If it does acetone labeled in 
the carbonyl position should label glucose according to the 
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following equation: 
CH^-C^O-C^-—^CH3-Ci40-C00H —■2, 5> 1, 6 -C14 glucose. 
Metabolism of acetone by the carboxylation and cleavage 
mechanisms should label glucose solely in the 3, 4 positions. 
Accordingly Sakami and Lafaye (65) administered Cl4-carbonyl- 
labeled acetone to rats and found higher activity in the 2, 5 
than in the 1, 6 positions of glucose derived from liver gly¬ 
cogen. Thus there is evidence that to a certain extent animal 
tissues may be able to convert acetone to a 3-carbon intermediate 
of glycolysis. However, it has already been pointed out that 
acetone is not an important metabolic product of acetoacetate. 
Thus it would seem that for the greatest part any conversion of 
acetoacetate to glycogen in tissues under physiological con¬ 
ditions must follow the established pathway of beta-oxidation 
to 2 acetyl-CoA which then traverses the Kreb's cycle. As has 
already been pointed out, it is theoretically possible to pro¬ 
duce an actual synthesis of glycogen by this pathway. 
X The Sffect of Growth Hormone on Cardiac Glycogen. 
If the heart does not synthesize glycogen from ketone 
bodies what is the explanation for the increased cardiac gly¬ 
cogen in animals with ketonemia? Certainly it is not due to 
increased insulin levels for insulin secretion is decreased in 
diabetes. Cruickshank and Startup concluded that the primary 
defect in the diabetic heart is a failure to oxidize carbo¬ 
hydrate, presumable secondary to a lack of insulin (66). Yet 
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is the increased cardiac glycogen in fasting animals due to 
insulin deficiency? Illingworth and Russell (67) gave fasting 
rats insulin and found no effect on the increased cardiac gly¬ 
cogen. Bogue et al. (68) concluded from studies on the dog 
heart-lung preparation that glucose and not lactate was a source 
of cardiac glycogen. Yet Lackey, Bunde and Harris (55) could 
find no correlation between cardiac glycogen levels and the 
concentration of glucose in the blood. 
In 1951 Illingworth and Russell (67) found that fasted rats 
injected with growth hormone (1-2 mgm./lOO 8m.) exhibited a 
marked increase in cardiac glycogen as compared to fasted controls. 
In 1956 Russell and Bloom (68) demonstrated that hypophysectomy 
entirely prevented the increment in cardiac glycogen normally 
observed in rats under fasting conditions, whereas the giving 
of growth hormone to hypophysectomized fasted rats restored the 
cardiac glycogen to the same levels seen in intact fasted con¬ 
trols. Adrenalectomy did not significantly affect the cardiac 
glycogen in either fasted or fed animals. Hence the presence 
of growth hormone appears essential to the production of the 
rise in heart glycogen observed in the fasting state. In unfasted 
animals hypophysectomy produced no change in cardiac glycogen 
or elevated it slightly. In rats previously fasted and then fed 
glucose growth hormone (1 mgm./lOO 8m.) not only prevented the 
fall in cardiac glycogen normally observed under these con¬ 
ditions but caused it to rise above fasting levels. Adrouny 
and Russell (69) further demonstrated that growth hormone car 
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simulate the effects of fasting on the heart glycogen when 
given to fed animals and that feeding does not inhibit the ac¬ 
tivity of the hormone. In summary it appears that fasting may 
stimulate the secretion of growth hormone by the pituitary 
and it may be that diabetes and other conditions producing 
ketosis act likewise. 
By what mechanism does growth hormone increase the gly¬ 
cogen content of the heart? Russell and Bloom suggest three 
possibilities: 
1) Increased uptake of glucose from the blood. 
2) Inhibition of utilization of stored glycogen. 
3) Formation of glycogen from non-carbohydrate pre¬ 
cursors within the heart. 
In view of the anabolic action of growth hormone it is unlikely 
that it would produce gluconeogenesis from amino acids in the 
heart. Also there is no good evidence of the conversion of 
fats to glycogen in the heart under physiological conditions. 
Russell and Bloom point out that there is little evidence that 
growth hormone increases uptake of glucose by other tissues 
but that there is evidence that the hormone blocks carbohydrate 
utilization. Thus 2) would seem the most likely8 
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B. Purpose of the Present Investigation 
Much evidence has been presented indicating that the heart 
is unable to synthesize glycogen from ketone bodies. Neverthe¬ 
less, the question is not completely settled for it is not yet 
known whether a heart thoroughly depleted of its glycogen content 
and then given a ketone body as the sole metabolite can resynthe¬ 
size glycogen. Admittedly this is subjecting the heart to 
rather unphysiological conditions. However, if carbohydrate is 
essential to normal cardiac function and if the heart has any 
enzyme system capable of producing gluconeogenesis from ketone 
bodies it should become evident under such demanding circumstances. 
Is there then a pathway, normally unused, by which the heart can 
produce glycogen in an emergency? 
Accordingly, the present investigation was undertaken to 
determine if a heart so depleted of its glycogen can resynthesize 
this carbohydrate from a ketone body, beta-hydroxybutyric acid. 
The technique of heart perfusion seemed the best way to study 
this problem. The frog's heart was chosen because of the ease 
with which it can be perfused and because its metabolism in many 
ways is similar to that of the mammalian heart (70, 76, 77, 78, 79). 
Since Bogue et al. (75) demonstrated quite conclusively that 
the heart is able to synthesize glycogen from glucose it seemed 
indicated to determine what effect, if any, ketone bodies have 
on this conversion. If ketone bodies are not converted to 
glycogen themselves do they increase the cardiac glycogen by 
means of a sparing action on glucose? In other words, can the 
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heart utilize ketone bodies for energy and thereby synthesize more 
glycogen from glucose than would be the case if glucose were 
present alone? 
In view of the work by Russell et al. (67? 68„ 69) demon¬ 
strating the glycogenic effect of growth hormone on heart muscle 
it was also decided to study the influence of this hormone on 
the possible synthesis of glycogen from ketones and from glucose 
in a frog's heart first depleted of all of its glycogen. Experi¬ 
ments to determine the effect of the hormone on cardiac glycogen 
in the intact frog were also performed. 
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II. MATERIALS AND METHODS 
A. Animals —- American bullfrogs weighing 250 - 450 Gm. apiece 
were used in the experiments* Fresh shipments of frogs were 
obtained and used every two weeks. The animals were kept in 
a fasting state at a temperature of approximately 4° C. 
B. Equipment: 
1. Desiccator jar used as anaerobic chamber. 
2. Perfusion apparatus as described below. 
C. Chemicals used in depletion of cardiac glycogen and perfusion of 
the heart. 
1. Nembutal (sodium pentobarbital). 
2. Epinephrine -- 1:1000 concentration. 
3. Glutathione -- reduced. 
4. Beta-hydroxybutyric acid by Fisher Scientific Company. 
5. Purified growth hormone made by Armour Laboratories. 
6. Dextrose. 
7. Physiological salt solution for perfusion as described by 
Clark et al. (70). Solution consisted of: 
NaCl, 0.65# 
CaCl2, 0.024# 
KC1, 0.015# 
Na phosphate, 0.02# (pH * 7.6) in distilled H20. 
8. Bottled oxygen and nitrogen gases. 
D. Quantitative determination of tissue glycogen. 
1. Chemicals: 
a) KOH, 3# and 30# 
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b) EtCH, 95% 
c) HC1, 2.5% 
d) Phenol red, 1% 
e) Copper Reagent. A 
NaHCO-j 
Ka2S0^ 
Rochelle salt 
25.0 Gm./L 
25.0 Gm./L 
20.0 Gm./L 
200.0 Gm./L 
f) Copper Reagent B 
Cu S04»5H2) 15/ with 1-2 gtts. cone. HgSO^/lOOml. 
g) Arseno Molybdate Soln. 
Ammonium molybdate, 25 Gm. in 400 cc H^O. 
H2SO4, cone. 21 cc. 
Na2HAs04«7H20, 5 Gm. in 25 cc H2O. 
Incubate at 37° for 24 - 48 hrs. 
2. Methods: 
The disintegration of tissue and hydrolysis of glycogen 
to glucose were carried out according to the method of 
Good, Kramer and Somo gyi (71). G-luco se was analyzed 
by the method of Nelson (74). 
E. Perfusion Apparatus; The isolated beating heart was suspended 
in a container of physiological solution by means of cannulas 
inserted into the sinus venosus and into the two aortas. It 
was kept at a temperature of 25 - 27°C. by warm lights or 
by surrounding its container with cool water, depending on 
the room temperature. Situated above the heart was a flask 
containing the perfusate through which 02 bubbled. From this 
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flask the solution dripped into the cannula inserted in the 
sinus venosus. The heart then pumped it against a resistance of 
about 1 cm. of HpO into a second flask. From here it was blown 
by air under pressure back up to the first vessel. Thus 
the same solution could be recirculated through the heart as 
many times as was desirable. 
Adequate oxygenation was assured by the bubbling of O2 
through the perfusate before it entered the heart and by 
blowing the fluid back up to the first flask by pressurized air. 
The resistance the heart pumped against was kept low to insure 
as nearly complete emptying of the ventricle with each contraction 
as was possible. 
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III. EXPERIMENTAL PROCEDURE 
A. Depletion of Cardiac Glycogen. 
The frogs were injected intraperitoneally with approximately 
20 mgm. sodium pentobarbotal per 100 Gm. frog weight. After 
anesthesia occurred the heart was exposed by a ventral midline 
incision opening the peritoneal and pleural cavities. The ab¬ 
dominal and chest walls were reflected and the pericardium was 
stripped from the heart, the circulation of blood being left intact. 
The frog with its heart thus exposed and still beating was 
placed, ventral side up in a desiccator jar. The physiological 
salt solution described in the previous section was allowed to 
drip on the heart at a rate of 12 - 15 drops per minute from a 
container placed within the desiccator. Epinephrine was added to 
this solution at a concentration of 1/500,000 to stimulate the 
heart and a few mgm. of reduced glutathione were used to keep the 
epinephrine in a reduced state. The air in the desiccator was 
then displaced by 100/ nitrogen and the chamber sealed to make 
it air tight. The heart, in situ in the frog and with isotonic 
solution dripping on it to prevent drying:, continued to beat and 
pump blood in this anaerobic atmosphere. 
After 30 minutes to 4 hours, sometimes longer, in this 
nitrogen-filled chamber a small area developed at the base of the 
ventricle which appeared white in contrast to the red color of 
the remaining myocardium. If the preparation was then removed 
to an aerobic atmosphere the white area of muscle disappeared 
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but reappeared shortly when the heart was reintroduced into 
the anaerobic chamber. As the heart continued to beat anaero¬ 
bically the white area, which resembled scar tissue and did not 
contract, enlarged continuously until it involved the entire 
ventricle. At this stage the ventricle could not be revived by 
the introduction of oxygen. 
When the white area which grossly re.sembled an old infarct 
reached a size about 3X3 mm. in area the entire ventricular 
myocardium could be shown to be depleted of glycogen (see under 
"Results”). The heart, still contracting actively, could then be 
removed from the anaerobic chamber and perfused as a preparation 
with ventricles free of glycogen. All glycogen determinations 
were carried out on viable ventricular myocardium not involved 
by the "infarct" (see "Discussion" for quotes). The auricles 
were not analyzed because of the difficulty in excluding sinus 
venosus and aortic tissue from the specimen. Also it would be 
difficult to be certain the ratio of ventricular to auricular 
tissue was the same each time. Hence, though the entire heart was 
perfused, only the ventricles were analyzed for glycogen. Only 
hearts which developed the "infarct" were perfused though it was 
found that some hearts became depleted of glycogen before they 
developed the white area. Other hearts never developed the 
scarred appearance until long after they had ceased beating from 
exhau stion. 
B. Berfusi on of the Heart. 
Following the development of the "infarct" about 3 X 3 mm. in 
20 

area at the base of the ventricle the frog was removed from the 
anaerobic chamber. Immediately a glass cannula was inserted into 
the sinus venosus and the blood washed from the heart with the 
■physiological solution. The two aortas were then cannulated with 
polyethylene tubing and the heart removed from the frog and 
attached to the perfusion apparatus. The heart was then perfused 
with 400 cc. of the physiological salt solution to which had 
been added substances such as glucose, beta-hydroxybutyric acid, 
etc. in known amounts. All solutions were adjusted to a pH of 7.6. 
After the heart had been perfused for the desired length of 
time the ventricle, excluding the "infarcted1* portion, was removed, 
blotted three times to remove excess fluid and dropped into a 
weighed centrifuge tube containing 2cc. of 30% KOH. The tube 
was reweighed rapidly and then heated over an open flame to 
disintegrate the tissue. Glycogen was then determined quanti¬ 
tatively. About 20 seconds elapsed from the time the ventricle 
was cut from the auricles to the time it was disintegrated by 
boiling. 
In addition to the perfusions a set of in-vivo experiments 
was performed in which fasting frogs were injected intraperitoneal- 
ly with either growth hormone or saline. The ventricles were then 
analyzed for glycogen in the two groups of animals and the 
re su11 s c ompared. 
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IV. RESULTS 
The results of this investigation are summarized in Tables 
I to IV. 
Table 1: 
It should be noted that two types of controls were used for 
the perfusion experiments. The values listed in line 1 were 
obtained on hearts removed from frogs under Nembutal anesthesia 
with immediate determination of ventricular glycogen. Thus the 
value of 1238 i 74 mg$ represents the glycogen content of the 
ventricles of frogs kept without food two weeks or less. Though 
not indicated on the table there was no correlation bet-ween the 
level of cardiac glycogen and the duration of fasting within 
this two week period. However, one frog sacrificed after three 
months of fasting (not included in Table I) had a ventricular 
glycogen content of 2450 mg%, more than 900 mg$ greater than that 
of any frog in the same shipment kept less than two weeks. Un¬ 
fortunately, no other animals were kept for such an extended 
period of time. 
Line 2 of Table I demonstrates that hearts which were allowed 
to beat in an anaerobic atmosphere until the 11 infarct" developed 
and were then cannulated uniformly contained no glycogen in the 
ventricles. These hearts therefore serve as the controls for 
hearts that were treated in the same manner but were then perfused 
with various metabolites (lines 3 - 6 of Table I and Tables II 
and III). It is obvious that the 15 to 20 minutes in an aerobic 
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TABLE I 
Determination of Glycogen Synthesis in Glycogen-Free Frog 
Hearts Perfused with Glucose and Na Beta-hydroxybutyrate 
Experiment 
Number of 
Animals 
Ventricle 
Glycogen 
Mg>1 
Duration of 
Perfu sion 
Hrs. 
Controls: 
1. Normal animal 12 1238 £ 74* 0 
2. After anaerobic period 
and cannulation 7 0 ± 0 0 
Perfused with indicated 
substance after depletion 
of glycogen: 
3. Sodium beta-hydroxy¬ 
butyrate, 100 mg/o 
6 
29 i 17 4, 6, 12 
See Table II 
4. Sodium beta-hydroxy¬ 
butyrate, 25 fflg^ 3 5 £ 4 6 
5. Glucose, 100 mg^ 6 588 £ 81 6 
6. Glucose, 100 mg% + 
Sodium beta-hydroxy¬ 
butyrate, 100 mg% 
6 595 ± 86 6 
* Standard error as calculated from the formula S. E. 
N(N-1)» 
where x eoxuals the difference between the mean and the experimen- 
value and N is the number of experiments. 
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atmosphere required for cannulation did not produce any glycogen 
synthesis from possible products of glycogenolysis contained 
within the heart muscle. 
Line 5 demonstrates that hearts perfused with 100 mgm. 
glucose per 100 cc. perfusate for six hours synthesized and 
stored an amount of glycogen equal to 50% of the glycogen content 
of the heart in an intact untreated animal (line 1), The small 
amount of glycogen synthesis indicated in the hearts perfused 
with beta-hydroxybutyrate alone (lines 3 and 4) is of no signi¬ 
ficance in view of the relatively large standard error obtained. 
Table I also indicates that whether hearts were perfused with 
glucose alone or with glucose plus ketone, the same amount of 
glycogen was formed. 
Table II: 
This table is an analysis of lines 3 and 4 of Table I. Here 
it can be seen that 7 of the 9 hearts perfused with ketone showed 
no glycogen formation, including the one perfused with 100 mgm. 
per 100 cc. for twelve hours (the values of 14 and 16 mg/2 are 
well within the limits of error of the methods used to measure 
glycogen and glucose). That leaves a significant amount of 
glycogen in only two of the nine hearts perfused with beta- 
hydroxybut-yric acid as the only metabolite. The concentration 
of ketone and the duration of perfusion were not significant. 
Table III: 
This table summarizes the results of studies to determine 
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TABLE II 
An Analysis of Lines 3 and 4 of Table I 
Experiment No. 
Mg >1 
Gone. of Sodium 
Beta-hydroxybuty- 
rate perfused. 
Duration of 
Perfusion 
Hrs. 
Ventricle 
Glycogen 
Mg/£ 
1 100 4 65 
2 100 4 16 
3 100 6 0 
4 100 6 95 
5 100 6 0 
6 100 12 0 
7 25 6 0 
8 25 6 0 
9 25 6 14 
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TABLE III 
Effect of Growth Hormone on Glycogen Synthesis from Glucose and 
Sodium Beta-Hydroxybutyrate in the Perfused Frog Heart 
Experiment 
Number of 
Animals 
Ventricle 
Glycogen 
Mg# 
Duration oJ 
Perfu si on 
Hrs. 
Hearts perfused with indi- 
cated substance after deple- 
tion of glycogen: 
1. Glucose, 100 mg# and 
Growth hormone, 2 mg# 3 435 t 158 6 
2, Glucose, 100 mg#, 
Na beta-hydroxybutyrate, 
100 mg# and 
Growth hormone, 2 mg# 
3 548 i 21 6 
3. Na beta-hydroxybutyrate, 
100 mg# and 
Growth hormone, 2 + 1+1 mg#* 
3 166 1 40 6 
4, Na beta-hydroxybutyrate, 
100 mg#, 
Growth hormone, 2+1+1 rag#* 
and 
Insulin, 2+2 units**-*- 
3 100 i 44 6 
5. Growth hormone, 2+1+1 mg#* 3 139 t 66 6 
* 2 mg/o of growth hormone was added at the beginning of the per' 
fusion and 1 mg# at the end of 2 and 4 hours. 
** 2 units of insulin were added at the beginning of the perfusion 
and 2 units at the end of 3 hours. 
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the effect of growth hormone on glycogen synthesis in the perfused 
heart. All hearts were first depleted of glycogen by the method 
previously described. Unfortunately the number of experiments 
performed in each case was small. 
When one considers the large standard error of 158 mgy? in 
line 1 of Table III there is no significant difference between 
the value of 435 df 158 mg/e of ventricular glycogen obtained with 
glucose and growth hormone and the 588 £ 81 mg/e shown in line 5 
of Table I where glucose alone was perfused. Likewise the value 
obtained when growth hormone was added to ketone and glucose 
(548 £ 21 mg%, line 2, Table III) is the same as the 595 86 mgfo 
of glycogen synthesized from glucose and beta-hydroxybutyric 
acid when the hormone was not present (line 6, Table I). Three 
hearts perfused with growth hormone alone (line 5, Table III) 
developed an average glycogen content of 139 — 66 mg%, Combining 
ketone (line 3» Table III) and ketone plus insulin (line 4, Table 
III) with the growth hormone did not change the amount of glycogen 
synthesized. 
Table IV: 
The results listed in this table demonstrate that frogs 
injected, with 1.0 mgm. of growth hormone intraperitoneally at 
0, 24 and 48 hours and sacrificed 8 hours later showed the same 
amount of cardiac glycogen as suitable controls injected with 
saline. It should be noted that these control animals (line 1, 
Table IV) have a much higher level of cardiac glycogen than the 
animals in line 1, Table I ---2090^65 mg$ as compared to 1238 it 74 mg)o 
27 

TABLE IV 
Effect of Growth Hormone on Cardiac Glycogen of the Frog 
In-Vivo 
Experiment Number of 
Animals 
Ventricle 
Glycogen 
Mg?b 
Controls: 
1. Fasting frogs injected intra- 
peritoneally with 0.7 cc iso¬ 
tonic saline at 0, 24 and 48 
hours and sacrificed 8 hours 
after the last injection. 
3 2090 t 65 
Experimentals: 
2. Fasting frogs injected intra- 
peritoneally with 1.0 mgm. 
growth hormone per 100 Gms. 
frog weight (0.7 cc total) at 
0, 24 and 48 hours and sacri¬ 
ficed 8 hours after the last 
injection, 
4 2018 t 144 
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V. DISCUSSION 
A. Depletion of Cardiac >gen: 
It has long been known that anoxia rapidly lowers the glycogen 
content of the myocardium (72, 73)® In 1937 Bogue, Evans and 
Gregory (75) demonstrated by means of the dog heart-lung 
preparation that epinephrine can also deplete the heart of its 
glycogen. In the present series of experiments advantage was 
taken of both of these methods to produce glycogenolysis. 
However, since the epinephrine was simply allowed to drip on the 
external surface of the frog's heart it is questionable how 
important a role it played in this respect. Nevertheless, it 
did appear to strengthen the heart beat which would indicate 
that it penetrated the muscle cells. 
In the desiccator the perfusate of the heart was of course 
the frog's own blood, the circulation having been left intact. 
This method of depleting the heart's glycogen worked very well 
except in a few instances where the flow of blood was sluggish, 
usually due to hemorrhage in preparing the specimen. In these 
eases the heart would contract poorly and eventually stop. 
Such specimens were discarded. 
The nature of the white area that developed in the ventricles 
after the period of anaerobiasis cannot be stated definitely 
since histological studies were not performed. It resembled an 
old infarct resulting from coronary occlusion in the mammalian 
heart in that it appeared ischemic and did not contra.ct. However, 
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by strict definition an infarct is a local area of necrosis 
resulting from vascular obstruction. Since the frog has no 
coronary arteries this was not strictly an infarct, though it 
resulted from anoxia. Hence I use the word "infarct'* in this 
modified sense and have put it in quotation marks. 
In all the hearts analyzed the infarct signaled that the 
entire ventricular myocardium was depleted of glycogen. In 
general, the stronger and more rapid the contractions the sooner 
the infarct developed. However, occasionally a heart was found 
that did not develop this area of necrosis even after many hours 
of beating anaerobically, even though it could be demonstrated 
to be depleted of glycogen. In summary then, all hearts 
developing infarcts were found to be depleted of glycogen, though 
the converse was not always true. Thus hearts could continue 
to beat though free of glycogen. However, when such hearts were 
perfused aerobically with only the physiological salt solution 
they beat poorly, often stopping after an hour or two. There¬ 
fore no control series of six hour perfusions with just the salt 
solution could be carried out. In contrast the addition of glucose 
or ketones to the perfusate caused the hearts to beat strongly 
for long periods of time. 
Clark et al, (70) found that hearts containing glycogen would 
beat for 24 hours or more with just the physiological salt 
solution. This would seem to indicate that muscle glycogen is 
essential to normal cardiac function when no source of energy is 
present in the perfusate such as ketone bodies, even though the 
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latter may rot give rise to glycogen. 
£. Glycogen Levels in Normal Frog' s Heart: 
In the work by Clark et al. (76) on the carbohydrate content 
of the frog's heart it was found that the amount of glycogen 
varied greatly in different batches of animals and in general was 
higher in winter than in summer. Also in one of his papers 
Clark makes the statement that the carbohydrate content rose in 
proportion to the time the frogs were kept in captivity. However*, 
it is not clear whether the animals were fed or not. In the 
present perfusion experiments these variations were overcome by 
first depleting the hearts of all their glycogen. 
However, the normal variability of the frog cardiac glycogen 
probably plays a role in explaining the difference between the 
1238 ir 74 mg% of ventricular glycogen in the control animals in 
Table I and the 2090 + 65 mg/£ found in the controls in Table IV. 
The frogs of line 1, Table I arrived in June and September, 1955 
and the glycogen content was essentially the same in both batches. 
Those in line 1 (and line 2) of Table IV were obtained in Septem¬ 
ber, 1957. Hence frogs in Table 1 and Table IV cannot be compared. 
Also it is not known how long the frogs were fasted before they 
arrived here from Louisiana. A long fasting period would explain 
the higher cardiac glycogen content of the controls in Table IV. 
Another difference is that the latter group of frogs received 
intraperitoneal saline, though Lackey (56) found this did not 
alter the cardiac glycogen of rats. 
The one frog that was fasted for three months (see "Results") 
31 

and found to have a much higher concentration of cardiac glycogen 
than other animals in the same shipment is in line with the 
frequently made observation that fasting elevates the heart 
glycogen. 
C. Effect of Beta-Hydroxybutyric Acid on Cardiac Glycogen. 
Can a net synthesis of glycogen be produced from beta- 
hydroxybutyric acid? The two hearts that had a glycogen content 
of 65 and 95 mg/® after being perfused with ketone alone provide 
the only suggestion of such a conversion. When the large amount 
of glycogen synthesized from glucose (588 ir 81 mg%) is considered 
plus the fact that 7 of the 9 hearts perfused with ketone alone 
produced no glycogen* the values of 65 and 95 fflg> cannot be 
construed as evidence that beta-hydroxybutyric acid produces 
glycogen. Another explanation for this small amount of glycogen 
must be sought. 
One possibility is that the hearts were not entirely depleted 
of glycogen before they were perfused. Though this cannot 
definitely be ruled out, it is not likely when one considers that 
the 7 hearts measured for glycogen content after development of 
the Infarct uniformly showed no glycogen whatsoever. Another 
explanation is that glycogen was formed from precursors contained 
within the myocardium. Clark et al. (70) found that glycogen 
represented only 1/3 of the total reducing substances of the 
frog heart. Thus, though the infarct indicated the heart was 
depleted of glycogen other carbohydrates or carbohydrate pre¬ 
cursors such as pyruvic or lactic acid may have been present. 
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It is also possible that the heart formed the glycogen from certain 
a.mino acids. However, evidence against such precursors playing 
a role 'are the seven hearts in Table II that demonstrated no 
glycogen synthesis. It is unfortunate that a series of frogs 
perfused with just the salt solution for a period of a few hours 
could not be obtained. 
Further evidence against synthesis of gl,ycogen from ketone 
bodies is the finding that growth hormone plus beta-hydroxy- 
butyric acid produced no more glycogen than the hormone alone. 
Nor was there any evidence of a sparing action of ketone on 
glucose. This is shown by the fact that a combination of beta- 
hydroxybutyric acid with glucose produced no more glycogen than 
glucose alone. 
One problem that must be considered is what effect if any 
the period in the anaerobic chamber had on the normal metabolism 
of the heart. Were enzyme systems destroyed or adversely affected? 
Though this cannot be ruled out the excellent synthesis of 
glycogen from glucose is evidence that the enzyme systems re¬ 
mained intact and functioned normally. 
Is it likely that perfusing the heart with acetoacetic acid 
would have produced results differing from those obtained with 
beta-hydroxybutyrate? Meyer and Bow (60) found that the dog's 
heart metabolized acetoacetic acid by degradation to 2 acetyl-CoA 
which then entered the Kreb's cycle. Waters et al. (48) and 
Barnes et al. (49) found that bets,-hydroxybutyric acid was 
readily oxidized by the dog heart. The present series of experi¬ 
ments indicate the same is true for the frog's heart since hearts 
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perfused with ketone contract much more strongly and for a. 
longer time than hearts perfused with salt solution alone. It 
has also been noted (61) that butyrate is only metabolized by 
animal tissues by beta-oxidation to 2 acetyl GoA. By combining 
these facts it becomes evident that beta-hydroxybutyric acid must 
be oxidized to acetoacetic acid and not reduced to butyric acid 
in order to be utilized by the heart. Since the heart therefore 
converts beta-hydroxybutyrate to acetoacetate it is highly un¬ 
likely that perfusion with the latter substance would have given 
results differing from those obtained with the ketone body that 
was used. In this connection Lackey (56) found essentially the 
same increase in cardiac glycogen when either beta-hydroxyhutyric 
or acetoacetic acid was infused. 
Would acetone have given rise to glycogen hy formation of 
pyruvate? Meyer and Bow (58, 60) found no evidence suggestive 
of a conversion of acetoacetate to acetone to pjrruvate even 
though, as was previously mentioned, acetoacetic acid is decar- 
boxylated to acetone by animal tissues to a small extent. Hence 
it is unlikely that acetone would have formed glycogen in these 
experiments when beta-hydroxybutyric acid did not. 
C, Growth Hormones 
The experiments with growth hormone ( Tables III, IV ) 
do not confirm the findings of Russell and coworkers in 
rats that this substance increases the level of cardiac 
glycogen by acting as a hormone. As has been pointed out 
under ’‘Results'* the addition of growth hormone to glucose or 
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to glucose plus ketone did not increase the amount of glycogen 
synthesized. Though the hormone plus ketone produced a signi¬ 
ficant amount of glycogen whereas ketone alone did not, the amount 
formed was the same as was obtained with the hormone alone. 
Hence no evidence was found indicating that growth hormone in¬ 
creases glycogen synthesis from dextrose or stimulates formation 
from ketones. The in-vivo experiments (Table IV) also gave no 
evidence of increased cardiac glycogen in animals injected with 
growth hormone. Insulin also was inactive. 
Line 5 of Table III suggests a synthesis of glycogen from 
the amino acids of growth hormone, a finding reinforced by lines 
3 and 4 of the same table. Assuming the ventricle weighed 0.5 Gm. 
(rarely did it weigh slightly more), a glycogen level of 166 mg/£ 
(line 3, Table IV) would mean a total glycogen content of 0.83 mgm. 
Four milligrams of growth hormone per 100 cc. of salt solution 
was perfused during the 6 hour period or a total of 16 mgm. of 
hormone since 400 cc. of perfusate was used In each experiment. 
This is a more than sufficient amount to explain the synthesis 
of glycogen even if it is assumed the atria synthesized a similar 
amount. That growth hormone in combination with glucose did not 
produce more carbohydrate than glucose alone might be interpreted 
to mean that the heart will only synthesize a fixed amount of 
glycogen in a limited amount of time no matter how many pre¬ 
cursors are available. 
Why did these experiments fail to confirm Russell's finding 
that growth hormone produces an increased level of cardiac gly¬ 
cogen? First there is the problem of species difference. 
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Russell worked with rats; these experiments were done with frogs. 
The failure of the in-vitro experiments to confirm Russell's 
findings might be attributed to growth hormone stimulating gly- 
cogenesis from some substance not present in the perfusion system. 
However, this will not explain the failure to demonstrate ele¬ 
vated cardiac glycogen levels in the frogs injected intraperi- 
toneally with the hormone. In connection with the in-vivo ex¬ 
periments it should be noted that the control animals in line 1 
of Table IV have a very high glycogen content. Perhaps hearts 
with a lower concentration of carbohydrate would, have synthesized 
or stored glycogen more readily in response to growth hormone. 
In both the in-vivo and the in-vitro experiments the dosage 
of hormone was comparable to that used by Russell et al. 
Russell and Bloom (68) concluded that growth hormone probably 
increased cardiac glycogen by blocking its utilization. It may 
be that under the conditions of the perfusion experiments the 
heart would not readily utilize the glycogen it had synthesized 
and therefore growth hormone would be unable to play a role. It 
would be interesting to see if growth hormone interfered with 
the process of deglycogenation in the anaerobic chamber. Also 
it may be that the preparation of hormone used was inactive in 
frogs. 
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VI. CONCLUSIONS 
As regards amphibian cardiac function the following con¬ 
clusions may be drawni 
1) An anaerobic atmosphere plus epinephrine rapidly de¬ 
pletes the heart of its glycogen. The development of the infarct 
serves as an excellent indicator that the ventricle is devoid 
of this carbohydrate, 
2) Even when entirely depleted of glycogen the ventricle 
need not resynthesize it in order to contract. Its function, 
however, is greatly improved by the addition of a substance such 
as glucose or beta-hydroxybutyrate to the perfusing fluid. 
Hence, the amphibian heart appears able to utilize ketone bodies 
for energy as can the mammalian heart. 
In reference to the question of a net synthesis of glycogen 
from ketone bodies it is concluded that under the conditions of 
the present series of experiments no evidence for such a conver¬ 
sion could be obtained, even though the myocardium first was 
depleted of all glycogen. Therefore these experiments add to the 
generally held opinion that the animal body is unable to bring 
about such a synthesis. Nor was any sparing effect of ketone 
on glucose found. 
It is also concluded that under the present experimental 
conditions growth hormone, in its role as a, hormone, could not 
be demonstrated to elevate the cardiac glycogen in the frog. 
This is in contrast to the finding in the mammal (57? 68, 69) 
where growth hormone does increase the store of glycogen in the 
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heart, the increase being due to its hormonal action. However, 
the frog's heart may have synthesized glycogen from the growth 
hormone itself. 
The problem of why animals in ketosis show an increase in 
cardiac glycogen remains unsolved though the work by Russell et 
al. sheds much light on the problem. Certainly the increase does 
not appear to be due to a direct conversion of ketone bodies to 
carbohydrate. 
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VII. SUMMARY 
The hearts of American bullfrogs were first depleted of 
their glj^cogen content by placing the animal in an anaerobic 
environment and permitting epinephrine to drip on the exposed 
heart. It was found that the development of an "infarct11 in 
the ventricle served to indicate when the myocardium was de¬ 
void of glycogen. The heart was then removed from the animal and 
perfused with glucose, beta-hydroxybutyric acid and a combination 
of the two. From glucose and from glucose plus ketone the heart 
ventricle in six hours synthesized an amount of glycogen equal 
to 50% of that found in the normal frog ventricle. However, 
no synthesis could be demonstrated from ketone alone. 
The addition of growth hormone to the perfusate did not in¬ 
crease the synthesis of glycogen from glucose or induce any 
formation from ketone. Nor did the intraperitoneal injection of 
the hormone into fasting rats result in increased levels of 
glycogen in the myocardium. 
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